RxDoctor Payments Data

Krystal Bridwell, APRN

Family · Mount Pleasant, TXNPI 1629505912

Payments from drug & device makers

$1,058in general payments, 2019–2025

Across 52 payments — averaging $20.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corcept Therapeutics$225
  • Lilly USA, LLC$160
  • AbbVie$133
  • Novo Nordisk$57
  • Exact Sciences$51
  • Corium, LLC$51
  • plus $380 from 12 others

What the payments were for

  • Food & beverage$1,058100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,058 in reported general payments places this provider in the 70th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Medicare billing

Part B allowed, 2024
$38,104
Medicare patients
274
Services billed
2,478

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate20$21,453
JardianceEmpagliflozin19$20,442
LinzessLinaclotide17$19,960
OzempicSemaglutide19$17,113
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$13,013
Levothyroxine Sodium103$761
Atorvastatin Calcium86$651
Losartan Potassium65$598
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst43$576
Gabapentin47$536
SynthroidLevothyroxine Sodium13$502
Azithromycin119$453
Rosuvastatin Calcium36$414
Lisinopril36$373
Omeprazole39$367

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$15$21,45320 claims
AbbVieLinzess, Synthroid$133$20,46230 claims
Boehringer IngelheimJardiance$28$20,44219 claims
Novo NordiskOzempic$57$17,11319 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 15,456 family providers in Texas.

Other family in Mount Pleasant

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →